Full-Time

Medical Science Liaison

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$138.7k - $173.4kAnnually

+ Bonus + Equity Awards

Senior

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • PharmD or PhD in a related field required.
  • Targeting 5 years of progressively-responsible experience in the biopharmaceutical industry, including 3 years of experience as a field-based MSL.
  • Psychiatry or neurology experience strongly preferred.
  • Scientific, clinical and therapeutic area expertise.
  • Knowledge of regulatory, compliance, commercial, and clinical issues affecting the pharmaceutical and managed care industries.
  • Skilled as a poised and knowledgeable presenter of scientific information.
  • Excellent writing capabilities and strong demonstrated presentation skills, including presentations within external formats such as physician gatherings, medical congresses, etc.
  • Experience in preparation of materials for use by Medical Affairs, including reviewing/editing Promotional materials.
  • Knowledge of customer segments and market dynamics.
  • Excellent planning and organizational skills.
  • Ability to professionally collaboratively interact with all levels within the organization.
  • Skilled at negotiating with business partners or management and influencing leaders.
  • Ability to work independently and with cross-functional teams.
  • Excellent oral and written communication skills, including presentation and facilitation formats.
  • Demonstrated expertise in drug information communication.
  • Highly skilled and proficient with all MS Suites programs, including Outlook, Word, Excel, and PowerPoint.
  • Ability to travel up to 75% of time, with primary residence within the geographical area or near a major airport.
Responsibilities
  • Identifies and develops relationships with national and regional medical and scientific thought leaders, patient advocacy groups, and centers of excellence consistent with the strategy and objectives of Acadia’s Medical Affairs and Development Departments.
  • Engages national and regional thought leaders to align interests, discuss research and medical information, and participate in scientific exchange and education about current and emerging therapies.
  • Provides Phase 2 / 3b / 4 research trial site support and investigator-initiated research proposal cultivation and facilitation.
  • Develops and maintains scientific, clinical and therapeutic expertise for Acadia’s portfolio.
  • Cross-functionally collaborates, following all compliance guidelines, with regional field leadership partners including, HEOR-Field MSLs, Sales Representatives, Patient Access Leaders, and alike Business Leaders.
  • Provides strategic field insights.
  • Identifies disease concepts and compound characteristics that can be leveraged into product differentiation.
  • Provides appropriate scientific, clinical, and educational support for internal and external clients.
  • Represents the company at specific continuing educational events, programs, medical meetings and conventions.
  • Supports Commercial operations by participating in Speaker and Sales Representative Training.
  • Partners with the internal departments to ensure accurate delivery of medical and scientific information.
  • Other duties as assigned.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and forming strategic partnerships to enhance its research and market presence. The goal of Acadia Pharmaceuticals is to improve the quality of life for patients suffering from challenging neurological diseases through effective treatments.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia received Health Canada approval for Daybue to treat Rett syndrome.
  • The company entered an exclusive license agreement with Saniona for SAN711.
  • Acadia's partnership with Ryan Reynolds raises awareness for Parkinson's-related symptoms.

What critics are saying

  • New CCO Thomas Garner may disrupt existing operations and partnerships.
  • The SAN711 license agreement poses financial risks if outcomes aren't met.
  • Regulatory setbacks for trofinetide could impact market entry and revenue.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neurological disorders like Parkinson's and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia collaborates with Biovail for developing pimavanserin for multiple indications.

Help us improve and share your feedback! Did you find this helpful?